American Financial Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

American Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-90,000	Closed	-$882K	–	138
2019 Q4	$882K	Hold	90,000	–	–	0.08%	90
2019 Q3	$619K	Hold	90,000	–	–	0.05%	106
2019 Q2	$831K	Hold	90,000	–	–	0.07%	103
2019 Q1	$1.41M	Hold	90,000	–	–	0.12%	93
2018 Q4	$1.39M	Hold	90,000	–	–	0.13%	97
2018 Q3	$1.94M	Hold	90,000	–	–	0.19%	83
2018 Q2	$2.19M	Hold	90,000	–	–	0.21%	77
2018 Q1	$1.54M	Hold	90,000	–	–	0.15%	90
2017 Q4	$1.71M	Sell	90,000 -90,000	-50%	-$1.35M	0.18%	82
2017 Q3	$3.17M	Hold	180,000	–	–	0.33%	67
2017 Q2	$5.98M	Hold	180,000	–	–	0.57%	55
2017 Q1	$5.78M	Hold	180,000	–	–	0.53%	60
2016 Q4	$6.53M	Buy	+180,000	New	+$7.19M	0.63%	57

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

American Financial Group's TEVA Position: Q1 2020 in Review

American Financial Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2020, closing a stake of 90,000 shares — an estimated $882K sold.

American Financial Group first reported a position in TEVA in Q4 2016 and held it in 13 quarters. The position peaked at $6.53M in Q4 2016. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

American Financial Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2020 after selling out during the quarter.
American Financial Group sold 90,000 Teva Pharmaceutical Industries Limited shares in Q1 2020, an estimated $882K.
American Financial Group first reported a position in Teva Pharmaceutical Industries Limited in Q4 2016 and held it in 13 quarters.
American Financial Group's Teva Pharmaceutical Industries Limited position peaked at $6.53M in Q4 2016.
459 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2020.

Based on American Financial Group's 13F filing for Q1 2020, filed 12 May 2020.